sulfur dioxide has been researched along with Osteosarcoma in 2 studies
Sulfur Dioxide: A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P | 1 |
| Zhang, W | 1 |
| Deng, J | 1 |
| Zheng, Y | 1 |
| Weng, J | 1 |
| Yu, F | 1 |
| Wang, D | 1 |
| Zheng, M | 1 |
| Kang, B | 1 |
| Zeng, H | 1 |
| Li, Y | 1 |
| Qu, J | 1 |
| Zhang, P | 1 |
| Zhang, Z | 1 |
2 other studies available for sulfur dioxide and Osteosarcoma
| Article | Year |
|---|---|
Chain-shattering polymeric sulfur dioxide prodrug micelles for redox-triggered gas therapy of osteosarcoma.
Topics: Drug Carriers; Humans; Micelles; Osteosarcoma; Oxidation-Reduction; Polymers; Prodrugs; Sulfur Dioxi | 2022 |
Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Female; Humans; Irinotecan; Mice, Inbred BALB C; Micelles | 2020 |